Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction.
Colbeck, Emily J
Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction. [electronic resource] - Cancer immunology research 11 2017 - 1005-1015 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
2326-6074
10.1158/2326-6066.CIR-17-0131 doi
Animals
Dendritic Cells--immunology
Endothelium, Vascular--immunology
Lymphocyte Depletion
Lymphocytes, Tumor-Infiltrating--immunology
Lymphotoxin beta Receptor--immunology
Methylcholanthrene
Mice
Neoplasms--chemically induced
Receptors, Tumor Necrosis Factor--immunology
T-Lymphocytes, Regulatory--immunology
Treg Depletion Licenses T Cell-Driven HEV Neogenesis and Promotes Tumor Destruction. [electronic resource] - Cancer immunology research 11 2017 - 1005-1015 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
2326-6074
10.1158/2326-6066.CIR-17-0131 doi
Animals
Dendritic Cells--immunology
Endothelium, Vascular--immunology
Lymphocyte Depletion
Lymphocytes, Tumor-Infiltrating--immunology
Lymphotoxin beta Receptor--immunology
Methylcholanthrene
Mice
Neoplasms--chemically induced
Receptors, Tumor Necrosis Factor--immunology
T-Lymphocytes, Regulatory--immunology